{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:44:48Z","timestamp":1791521088643,"version":"4.3.4"},"reference-count":97,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Medicine and Pharmacy Carol Davila"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Psoriasis is a common chronic, immune-mediated, inflammatory disease with associated comorbidities. Common psoriasis-associated comorbidities include psoriatic arthritis, cardiovascular disease, metabolic syndrome, inflammatory digestive syndromes, and depression. A less studied association is between psoriasis and specific-site cancers. A key cell in the pathophysiology of psoriasis is the myeloid dendritic cell, which links the innate and adaptive immune systems, and therefore is involved in the control of cancer-prevention mechanisms. The relationship between cancer and inflammation is not new, with inflammation being recognized as a key element in the development of neoplastic foci. Infection leads to the development of local chronic inflammation, which further leads to the accumulation of inflammatory cells. Various phagocytes produce reactive oxygen species that cause mutations in cellular DNA and lead to the perpetuation of cells with altered genomes. Therefore, in inflammatory sites, there will be a multiplication of cells with damaged DNA, leading to tumor cells. Over the years, scientists have tried to assess the extent to which psoriasis can increase the risk of developing skin cancer. Our aim is to review the available data and present some information that might help both the patients and the care providers in properly managing psoriatic patients to prevent skin cancer development.<\/jats:p>","DOI":"10.3390\/cancers15092451","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T05:12:53Z","timestamp":1682399573000},"page":"2451","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Skin Cancer Correlations in Psoriatic Patients"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5906-8654","authenticated-orcid":false,"given":"Daniel","family":"Costache","sequence":"first","affiliation":[{"name":"II Dermatology Discipline, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horia","family":"Blejan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Poenaru","sequence":"additional","affiliation":[{"name":"Dermatology Department, Carol Davila University Central Emergency Military Hospital, 010825 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0381-5550","authenticated-orcid":false,"given":"Raluca","family":"Costache","sequence":"additional","affiliation":[{"name":"Internal Medicine and Gastroenterology Discipline, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"ref_1","unstructured":"Kang, S., Amagai, M., Bruckner, A.L., and Enk, A.H. (2019). Fitzpatrick\u2019s Dermatology, McGraw-Hill Education. [9th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modeling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"ref_3","first-page":"200","article-title":"Managing comorbid disease in patients with psoriasis","volume":"340","author":"Boehncke","year":"2010","journal-title":"BMJ (Online)"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Mechanisms of Disease: Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jamadermatol.2019.3056","article-title":"Association of Psoriasis with the Risk of Developing or Dying of Cancer: A Systematic Review and Meta-analysis","volume":"155","author":"Trafford","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5455\/msm.2021.33.30-33","article-title":"Smoking Cigarettes and Consuming Alcohol in Patients with Psoriasis","volume":"33","author":"Salihbegovic","year":"2021","journal-title":"Mater. Sociomed."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/1744666X.2020.1754194","article-title":"Cancer risk in patients with psoriasis: Should we be paying more attention?","volume":"16","author":"Loft","year":"2020","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"ii30","DOI":"10.1136\/ard.2004.031120","article-title":"Psoriasis pathophysiology: Current concepts of pathogenesis","volume":"64","author":"Krueger","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1046\/j.1523-1747.1999.00749.x","article-title":"The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: A type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients","volume":"113","author":"Austin","year":"1999","journal-title":"J. Investig. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2133.1991.tb14774.x","article-title":"Psoriasis induced by interferon-alpha","volume":"125","author":"Funk","year":"1991","journal-title":"Br. J. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-\u03b1 production","volume":"202","author":"Nestle","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nm1605","article-title":"\u03b11\u03b21 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis","volume":"13","author":"Conrad","year":"2007","journal-title":"Nat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","first-page":"854","article-title":"Nitric oxide and oxygen radicals in infection, inflammation, and cancer","volume":"63","author":"Maeda","year":"1998","journal-title":"Biochem. (Mosc.)"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-017-9211-0_1","article-title":"p53 and hereditary cancer","volume":"85","author":"Merino","year":"2014","journal-title":"Subcell Biochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10025","DOI":"10.1073\/pnas.152333199","article-title":"Regional analysis of p53 mutations in rheumatoid arthritis synovium","volume":"99","author":"Yamanishi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/jnci\/86.2.120","article-title":"Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis","volume":"86","author":"Scholl","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.micro.54.1.615","article-title":"The disease spectrum of Helicobacter pylori: The immunopathogenesis of gastroduodenal ulcer and gastric cancer","volume":"54","author":"Ernst","year":"2000","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.3748\/wjg.v20.i18.5191","article-title":"History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer","volume":"20","author":"Graham","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_21","first-page":"184","article-title":"Non melanoma skin cancer (NMSC): Extramammary Paget\u2019s disease","volume":"123","author":"Eftimie","year":"2020","journal-title":"Rom. J. Mil. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jaad.2016.05.021","article-title":"Personal history of psoriasis and risk of nonmelanoma skin cancer (NMSC) among women in the United States: A population-based cohort study","volume":"75","author":"Dai","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_23","first-page":"778","article-title":"The risk of malignancy associated with psoriasis","volume":"137","author":"Margolis","year":"2001","journal-title":"Arch. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/jdv.13619","article-title":"Skin cancer in patients with psoriasis","volume":"30","author":"Egeberg","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1684\/ejd.2017.3032","article-title":"Reduced frequency of non-melanoma skin cancer in 72,739 patients with psoriasis: A retrospective study","volume":"27","author":"Paradisi","year":"2017","journal-title":"Eur. J. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1067\/mjd.2001.114576","article-title":"The risk of melanoma in association with long-term exposure to PUVA","volume":"44","author":"Stern","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaad.2010.04.046","article-title":"The risk of cancer in patients with psoriasis: A population-based cohort study in Taiwan","volume":"65","author":"Chen","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1523-1747.2000.00898.x","article-title":"Psoriasis, its Treatment, and Cancer in a Cohort of Finnish Patients","volume":"114","author":"Pukkala","year":"2000","journal-title":"J. Investig. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2133.1999.02655.x","article-title":"Malignant tumours and psoriasis: A follow-up study","volume":"140","author":"Frentz","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1684\/ejd.2014.2501","article-title":"Reduced frequency of melanoma in 72,739 patients with psoriasis: A retrospective study","volume":"25","author":"Paradisi","year":"2015","journal-title":"Eur. J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jdv.12165","article-title":"Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies","volume":"27","author":"Pouplard","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bjd.18887","article-title":"Methotrexate treatment for patients with psoriasis and risk of cutaneous melanoma: A nested case\u2013control study","volume":"183","author":"Polesie","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamadermatol.2020.1300","article-title":"Melanoma Risk in Patients Treated with Biologic Therapy for Common Inflammatory Diseases: A Systematic Review and Meta-analysis","volume":"156","author":"Esse","year":"2020","journal-title":"JAMA Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaad.2021.01.084","article-title":"Psoriasis and risk of cutaneous melanoma: A retrospective, comparative, registry-based cohort study","volume":"86","author":"Polesie","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/sj.jid.5700410","article-title":"The risk of lymphoma in patients with psoriasis","volume":"126","author":"Gelfand","year":"2006","journal-title":"J. Investig. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jaad.2008.12.031","article-title":"Treatments for psoriasis and the risk of malignancy","volume":"60","author":"Patel","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1365-4632.2011.05310.x","article-title":"The risk of developing non-melanoma skin cancer, lymphoma and melanoma in patients with psoriasis in Taiwan: A 10-year, population-based cohort study","volume":"51","author":"Lee","year":"2012","journal-title":"Int. J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archderm.139.11.1425","article-title":"Lymphoma rates are low but increased in patients with psoriasis: Results from a population-based cohort study in the United Kingdom","volume":"139","author":"Gelfand","year":"2003","journal-title":"Arch. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Butr\u00f3n-Bris, B., Daud\u00e9n, E., and Rodr\u00edguez-Jim\u00e9nez, P. (2021). Psoriasis Therapy and Skin Cancer: A Review. Life, 11.","DOI":"10.3390\/life11101109"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/jdv.12024","article-title":"Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis","volume":"27","author":"Blasco","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.0022-202X.2005.23681.x","article-title":"Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case-control study","volume":"125","author":"Naldi","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.1994.tb03380.x","article-title":"Smoking, alcohol and life events related to psoriasis among women","volume":"130","author":"Poikolainen","year":"1994","journal-title":"Br. J. Dermatol."},{"key":"ref_43","first-page":"9","article-title":"Psoriatics in Norway. A questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption","volume":"142","author":"Braathen","year":"1989","journal-title":"Acta Derm. Venereol. Suppl. (Stock.)"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archderm.141.12.1527","article-title":"Impact of obesity and smoking on psoriasis presentation and management","volume":"141","author":"Herron","year":"2005","journal-title":"Arch. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2133.1992.tb14818.x","article-title":"Smoking habits in psoriasis: A case control study","volume":"127","author":"Mills","year":"1992","journal-title":"Br. J. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1365-4362.2002.01595.x","article-title":"Frequent use of tobacco and alcohol in Chinese psoriasis patients","volume":"41","author":"Zhang","year":"2002","journal-title":"Int. J. Dermatol."},{"key":"ref_47","first-page":"65","article-title":"Psoriasis and smoking: Links and risks","volume":"6","author":"Naldi","year":"2016","journal-title":"Psoriasis (Auckl.)"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10552-020-01319-8","article-title":"The association between smoking and risk of skin cancer: A meta-analysis of cohort studies","volume":"31","author":"Arafa","year":"2020","journal-title":"Cancer Causes Control"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jdv.12164","article-title":"Alcohol consumption and psoriasis: A systematic literature review","volume":"27","author":"Brenaut","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_50","first-page":"75","article-title":"Psoriasis and alcohol","volume":"9","author":"Nordlind","year":"2019","journal-title":"Psoriasis (Auckl.)"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ijc.34253","article-title":"Baseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC)","volume":"152","author":"Severi","year":"2023","journal-title":"Int. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1523-1747.2003.12040.x","article-title":"Risk of malignancies in psoriasis patients treated with cyclosporine: A 5 y cohort study","volume":"120","author":"Paul","year":"2003","journal-title":"J. Investig. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaad.2011.04.004","article-title":"The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: A 30-year prospective study","volume":"66","author":"Stern","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/ije\/dyl197","article-title":"Risk factors for skin cancers: A nested case-control study within the Nurses\u2019 Health Study","volume":"35","author":"Han","year":"2006","journal-title":"Int. J. Epidemiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1150.e1","DOI":"10.1016\/j.amjmed.2009.06.021","article-title":"Comorbidities in Patients with Psoriasis","volume":"122","author":"Gottlieb","year":"2009","journal-title":"Am. J. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/0378-6323.115506","article-title":"Comorbidities in psoriasis","volume":"79","author":"Aurangabadkar","year":"2013","journal-title":"Indian J. Derm. Venereol. Leprol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1600-0625.2009.01034.x","article-title":"Topical hydrocortisone, clobetasol propionate, and calcipotriol do not increase photocarcinogenesis induced by simulated solar irradiation in hairless mice","volume":"19","author":"Lerche","year":"2010","journal-title":"Exp. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.bjc.6604796","article-title":"Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin\u2032s lymphoma: A population-based case-control study","volume":"100","author":"Jensen","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1054\/bjoc.2001.1931","article-title":"Non-melanoma skin cancers and glucocorticoid therapy","volume":"85","author":"Karagas","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1468-3083.2011.04226.x","article-title":"Oral prednisone use and risk of keratinocyte carcinoma in non-transplant population. The VATTC trial","volume":"26","author":"Baibergenova","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.annepidem.2014.05.009","article-title":"Systemic glucocorticoid use and early-onset basal cell carcinoma","volume":"24","author":"Troche","year":"2014","journal-title":"Ann. Epidemiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1523-1747.2002.01814.x","article-title":"p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet A-treated patients: Evidence for heterogeneity and field cancerization","volume":"119","author":"Stern","year":"2002","journal-title":"J. Investig. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199704103361501","article-title":"Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study","volume":"336","author":"Stern","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1468-3083.2012.04520.x","article-title":"Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review","volume":"26","author":"Archier","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2133.2005.06537.x","article-title":"The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: Early follow-up data","volume":"152","author":"Man","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/00015550410026948","article-title":"No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: A first retrospective study","volume":"84","author":"Weischer","year":"2004","journal-title":"Acta Derm. Venereol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1365-2133.2008.08776.x","article-title":"Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy","volume":"159","author":"Hearn","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40257-017-0337-2","article-title":"Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update","volume":"19","author":"Geller","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1097-0142(19820901)50:5<869::AID-CNCR2820500511>3.0.CO;2-V","article-title":"Methotrexate used for psoriasis and the risk of noncutaneous or cutaneous malignancy","volume":"50","author":"Stern","year":"1982","journal-title":"Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clindermatol.2009.03.003","article-title":"Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: Facts and controversies","volume":"28","author":"Naldi","year":"2010","journal-title":"Clin. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/kew214","article-title":"Disease-modifying anti-rheumatic drugs and non-melanoma skin cancer in inflammatory arthritis patients: A retrospective cohort study","volume":"55","author":"Lange","year":"2016","journal-title":"Rheumatology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/acr2.11187","article-title":"Adverse Effects of Low-Dose Methotrexate in a Randomized Double-Blind Placebo-Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation Reduction Trial","volume":"2","author":"Vanni","year":"2020","journal-title":"ACR Open Rheumatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/bjd.15170","article-title":"Methotrexate treatment and risk for cutaneous malignant melanoma: A retrospective comparative registry-based cohort study","volume":"176","author":"Polesie","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/art.23716","article-title":"Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate","volume":"59","author":"Buchbinder","year":"2008","journal-title":"Arthritis Care Res."},{"key":"ref_75","first-page":"282","article-title":"Non-Melanoma Skin Cancer Risk Among Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)","volume":"152","author":"Fuxench","year":"2016","journal-title":"JAMA Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04410.x","article-title":"The concept of psoriasis as a systemic inflammation: Implications for disease management","volume":"26","author":"Reich","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2133.2005.06563.x","article-title":"Traditional therapies in the management of moderate to severe chronic plaque psoriasis: An assessment of the benefits and risks","volume":"152","author":"Naldi","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0140-6736(01)06179-7","article-title":"Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: Nested cohort crossover study","volume":"358","author":"Marcil","year":"2001","journal-title":"Lancet"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2340\/00015555-0360","article-title":"Long-term follow-up of cancer risk in patients treated with short-term cyclosporine","volume":"88","author":"Reitamo","year":"2008","journal-title":"Acta Derm. Venereol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1067\/S0190-9622(03)01587-1","article-title":"Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: A nested cohort study","volume":"49","author":"Nijsten","year":"2003","journal-title":"Am. Acad. Dermatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00403-015-1593-8","article-title":"Drug safety of systemic treatments for psoriasis: Results from The German Psoriasis Registry PsoBest","volume":"307","author":"Reich","year":"2015","journal-title":"Arch. Dermatol. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/jdv.15019","article-title":"Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: A single-centre, retrospective, observational study","volume":"32","author":"Dickel","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_83","first-page":"223","article-title":"Malignant melanoma during treatment with fumaric acid esters-coincidence or treatment-related?","volume":"9","author":"Barth","year":"2011","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Costache, D.O., Feroiu, O., Ghilencea, A., Georgescu, M., C\u0103runtu, A., C\u0103runtu, C., \u021aiplica, S.G., Jinga, M., and Costache, R.S. (2022). Skin Inflammation Modulation via TNF-\u03b1, IL-17, and IL-12 Family Inhibitors Therapy and Cancer Control in Patients with Psoriasis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23095198"},{"key":"ref_85","first-page":"1211","article-title":"Adverse Medical Conditions Across Treatment Options in Patients with Psoriasis: A Claims-Based Analysis","volume":"17","author":"Wu","year":"2018","journal-title":"J. Drugs Dermatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e496","DOI":"10.1111\/jdv.17282","article-title":"Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non-biologic systemic therapies","volume":"35","author":"Mason","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/bjd.16715","article-title":"Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: A meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland","volume":"179","author":"Descalzo","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/bjd.15830","article-title":"Risk of cancer in patients with psoriasis on biological therapies: A systematic review","volume":"178","author":"Peleva","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/jdv.12675","article-title":"An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors","volume":"29","author":"Menting","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_90","first-page":"1","article-title":"Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management","volume":"12","author":"Yiu","year":"2022","journal-title":"Psoriasis (Auckl.)"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/annrheumdis-2016-209285","article-title":"Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: Results from a collaborative project of 11 European biologic registers","volume":"76","author":"Mercer","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaad.2016.10.006","article-title":"Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population","volume":"76","author":"Asgari","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_93","first-page":"f1939","article-title":"Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: Nationwide population based prospective cohort study from Sweden","volume":"346","author":"Raaschou","year":"2013","journal-title":"BMJ (Online)"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/CMR.0000000000000284","article-title":"Melanoma risk in patients with rheumatoid arthritis treated with tumour necrosis factor alpha inhibitors: A systematic review and meta-analysis","volume":"26","author":"Olsen","year":"2016","journal-title":"Melanoma Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/bjd.17084","article-title":"Comprehensive long-term safety of adalimumab from 18 clinical trials in adult patients with moderate-to-severe plaque psoriasis","volume":"180","author":"Leonardi","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bjd.12214","article-title":"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: Final results from 5 years of follow-up","volume":"168","author":"Papp","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jaad.2011.06.041","article-title":"Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): Results from analyses of infections and malignancy from pooled phase II and III clinical trials","volume":"66","author":"Gordon","year":"2012","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/9\/2451\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:23:02Z","timestamp":1760124182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/9\/2451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":97,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["cancers15092451"],"URL":"https:\/\/doi.org\/10.3390\/cancers15092451","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]}}}